不同肝胆疾病患者胆囊CT表现分析

doi:10.3969/j.issn.1672-5069.2019.03.034

实用肝脏病杂志 ›› 2019, Vol. 22 ›› Issue (3): 445-448.doi: 10.3969/j.issn.1672-5069.2019.03.034

不同肝胆疾病患者胆囊CT表现分析

黄文荣, 王慧, 李小华

571700 海南省儋州市海南西部中心医院放射科（黄文荣,王慧）;
海南医学院第一附属医院放射科（李小华）

收稿日期:2018-04-04 出版日期:2019-05-10 发布日期:2019-05-15
作者简介:黄文荣,男,36岁,大学本科,主治医师。E-mail:gongpangdi19960816@163.com
基金资助:
海南省自然科学基金资助项目（编号：2016812178）

Comparison of gallbladder CT manifestations between patients with chronic cholecystitis and with chronic liver diseases

Huang Wenrong, Wang Hui, Li Xiaohua

Department of Radiology, Western Central Hospital, Danzhou 571700, Hainan Province, China

Received:2018-04-04 Online:2019-05-10 Published:2019-05-15

摘要/Abstract

摘要： 目的分析比较慢性胆囊炎与慢性肝病患者胆囊CT表现的差异。方法 2014年11月~2017年10月我科诊治的慢性肝病患者52例（慢性乙型肝炎21例,乙型肝炎肝硬化26例,原发性肝癌5例）和慢性胆囊疾病患者32例（慢性胆囊炎20例,急性化脓性胆囊炎7例,急性胰腺炎合并胆囊炎3例,黄色肉芽肿性胆囊炎1例,坏疽性胆囊炎1例）,接受多排螺旋CT增强检查。结果慢性胆囊疾病患者囊壁厚径显著大于慢性肝病患者[（4.5±0.5）mm对（3.7±0.4）mm,P<0.05],囊壁强化、胆汁密度增高、邻近肝组织一过性强化显著多于慢性肝病组100.0%对75.0%、31.3%对5.8%和18.8%对0.0%,而胆囊周围粘连和胆囊周围积液发生率显著低于慢性肝病组[9.4%对75.0%和9.4%对28.9%,P<0.05]。结论胆囊炎和肝病性胆囊改变的CT表现存在差异,主要表现在胆囊改变、胆汁密度上升、胆囊周围积液等方面。

关键词: 胆囊疾病, 多排螺旋CT, 表现, 鉴别诊断

Abstract: Objectiv To compare the features of gallbladder CT manifestations between patients with chronic cholecystitis and with chronic liver diseases. Methods 52 patients with chronic liver diseases （chronic hepatitis B in 21,hepatitis B cirrhosis in 26 and primary liver caner in 5） and 32 patients with chronic cholecystitis were checked-up in our Department of Radiology beween November 2014 and October 2017. We analyzed their gallbladder CT manifestations. Results The gallbladder wall thickness in patients with chronic cholecystitis was significantly thicker than in patients with chronic liver disease [（4.5±0.5） mm vs. （3.7±0.4） mm,P<0.05],the incidences of cystic wall enhancement,increased bile density and transient enhancement of adjacent liver tissues were much higher than in patients with chronic liver diseases（100.0% vs. 75.0%,31.3% vs. 5.8% and 18.8% vs. 0.0%）,while the incidences of adhesion to peripheral tissues and gallbladder effusion were significantly lower than in patients with chronic liver diseases （9.4% vs. 75.0% and 9.4% vs. 28.9%,P<0.05）. Conclusion The CT manifestations of gallbladder in patients with chronic cholecystitis and liver disease are different,which might be helpful for clinicians to differentiate them.

Key words: Chronic cholecystitis, CT scan, Manifestations, Differential diagnosis

黄文荣, 王慧, 李小华. 不同肝胆疾病患者胆囊CT表现分析[J]. 实用肝脏病杂志, 2019, 22(3): 445-448.

Huang Wenrong, Wang Hui, Li Xiaohua. Comparison of gallbladder CT manifestations between patients with chronic cholecystitis and with chronic liver diseases[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 445-448.

参考文献

[1] Paci P,Mayo NE,Kaneva PA,et al.Determinants of variability in management of acute calculous cholecystitis. Surg Endosc,2018,32(4):1858-1866.
[2] Noh SY,Gwon DI,Ko GY,et al.Role of percutaneous cholecystostomy for acute acalculous cholecystitis:clinical outcomes of 271 patients. Eur Radiol,2018,28(4):1449-1455.
[3] Sato N,Kinoshita A,Imai N,et al.Inflammation-based prognostic scores predict disease severity in patients with acute cholecystitis. Eur J Gastroenterol Hepatol,2018,30(4):484-489.
[4] Ahmed O,Rogers AC,Bolger JC,et al.Meta-analysis of outcomes of endoscopic ultrasound-guided gallbladder drainage versus percutaneous cholecystostomy for the management of acute cholecystitis. Surg Endosc,2018,32(4):1627-1635.
[5] Castelijn DAR,Wattel-Louis GH.An acute acalculous cholecystitis in a returned travel couple. PLoS Negl Tropl Dis,2018,12(3):e0006177.
[6] Chen LH,Wang YF,Xu QH,et al.Omega-3 fatty acids as a treatment for non-alcoholic fatty liver disease in children:A systematic review and meta-analysis of randomized controlled trials. Clin Nutrit (Edinburgh,Scotland),2018,37(2):516-521.
[7] Sun S,Wang R,Fan J,et al.Effects of Danshen tablets on pharmacokinetics of atorvastatin calcium in rats and its potential mechanism. Pharmaceut Biol,2018,56(1):104-108.
[8] Mortezaee K,Khanlarkhani N.Melatonin application in targeting oxidative-induced liver injuries:A review. J Cell Physiol,2018,233(5):4015-4032.
[9] Koole SN,Lohman BG,van Unen J M. Emphysematous cholecystitis due to clostridium perfringens successfully treated by cholecystectomy. Acta Chir Belg,2016,116(1):54-57.
[10] Harrison JL,Turek BJ,Brown DC,et al.Cholangitis and cholangiohepatitis in dogs:A descriptive study of 54 cases based on histopathologic diagnosis(2004-2014). J Veterin Intern Med,2018,32(1):172-180.
[11] Gouveia C,Loureiro R,Ferreira R,et al.Performance of the choledocholithiasis diagnostic score in patients with acute cholecystitis. GE Portug J Gastroenterol,2018,25(1):24-29.
[12] Hong SA,Sung YN,Kim HJ,et al.Xanthogranulomatous cholecystitis shows overlapping histological features with IgG4-related cholecystitis. Histopathology,2018,72(4):569-579.
[13] Vieiro Medina MV,Gomez Sanz R,BRA Iisa E,et al.First case reported of Bouveret’s syndrome associated to duodenal and biliary perforation to retroperitoneum. Rev Esp Enferm Dig,2016,108(6):376-378.
[14] Honmyo N,Kuroda S,Kobayashi T,et al.Stepwise approach to curative surgery using percutaneous transhepatic cholangiodrainage and portal vein embolization for severe bile duct injury during laparoscopic cholecystectomy: a case report. Surg Case Rep,2016,2(1):27.
[15] Pascarella S,Dadparvas S.Chilaiditi sign on 99mTc-mebrofenin hepatobiliary scan mimicking bile leak in acute cholecystitis. Clin Nucl Med,2016,41(6):488-489.
[16] Cho JH,Sun JM,Lee SH,et al . Late-onset cholecystitis with cholangitis after avelumab treatment in non-small cell lung cancer. J Thorac Oncol,2018,13(3):e34-e36.
[17] Gupta A,LeBedis CA,Uyeda J,et al. Diffusion-weighted imaging of the pericholecystic hepatic parenchyma for distinguishing acute and chronic cholecystitis. Emerg Radiol,2018,25(1):7-11.
[18] Kim D,Iqbal SI,Ahari HK,et al.Expanding role of percutaneous cholecystostomy and interventional radiology for the management of acute cholecystitis:An analysis of 144 patients. Diagnost Intervent Imaging,2018,99(1):15-21.
[19] Takata H,Yoshida H,Hirakata A,et al.Recurrent gallstone ileus successfully treated with conservative therapy. J Nippon Med Sch,2015,82(6):300-303.

不同肝胆疾病患者胆囊CT表现分析

Comparison of gallbladder CT manifestations between patients with chronic cholecystitis and with chronic liver diseases

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	乔志忠. 超声造影定量分析鉴别肝脏局灶性结节性增生与原发性肝癌初步探讨[J]. 实用肝脏病杂志, 2019, 22(3): 421-424.
[2]	鲁雪红, 张源, 刘文亚. 多排螺旋CT三期增强与3.0T MR多期动态增强扫描诊断肝细胞癌的价值分析^*[J]. 实用肝脏病杂志, 2018, 21(5): 749-752.
[3]	杨敏, 卢明芹. 肝细胞性黄疸的诊断与治疗[J]. 实用肝脏病杂志, 2018, 21(2): 160-162.
[4]	贺欢，孔文洁，高峰. 295例食管静脉曲张病因及内镜下表现分析[J]. 实用肝脏病杂志, 2017, 20(5): 550-553.
[5]	徐秀红，姜赛龙，蒋春兰. 超声弹性成像与常规超声诊断肝脏局灶性良恶性病变价值比较[J]. 实用肝脏病杂志, 2017, 20(5): 629-630.
[6]	马进辉. 超声造影和微血流成像对不典型肝癌与肝局灶性结节性增生的鉴别诊断价值分析[J]. 实用肝脏病杂志, 2017, 20(4): 464-467.
[7]	王琨，王翠秀，王秀. 新生儿肝内胆汁淤积症与胆道闭锁临床特征比较[J]. 实用肝脏病杂志, 2017, 20(2): 228-229.
[8]	施美, 刘永华, 杨小军, 侯勇, 刘丽丽, 李艳, 张国梁. 先天性血色病1例[J]. 实用肝脏病杂志, 2016, 19(2): 235-236.
[9]	陈韬，叶昊，方文敏，吴亮，黄元成. 肝豆状核变性与慢性乙型肝炎重度患者临床特征分析^*[J]. 实用肝脏病杂志, 2015, 18(5): 486-490.
[10]	黄鼎祥. 多层螺旋CT门静脉成像对食管胃底静脉曲张出血风险评估的价值分析[J]. 实用肝脏病杂志, 2015, 18(3): 302-303.
[11]	郭涛, 袁农, 邢枫. 先天性肝纤维化如何诊断——附1例报告并文献复习[J]. 实用肝脏病杂志, 2014, 17(6): 639-642.
[12]	闫春伟, 李艳静. 肝脏局灶结节性增生的临床与病理学表现分析[J]. 实用肝脏病杂志, 2014, 17(5): 537-539.
[13]	李谨革综述，聂青和审校. 肝衰竭并发肝肾综合征临床诊治进展[J]. 实用肝脏病杂志, 2014, 17(2): 198-201.
[14]	陈贤, 王媛媛, 综述, 聂青和, 审校. 肝性脊髓病诊断与治疗研究进展[J]. 实用肝脏病杂志, 2012, 15(4): 366-368.
[15]	徐俊斌,胡琼文. 以四肢肌肉酸痛起病的肝豆状核变性1例[J]. 实用肝脏病杂志, 2011, 14(5): 383-383.